[HTML][HTML] Epigenetic alterations in cancer

S Ilango, B Paital, P Jayachandran… - Frontiers in Bioscience …, 2020 - imrpress.com
Genetic and epigenetic modifications in DNA contribute to altered gene expression in aging
and cancer. In human cancers, epigenetic changes such as DNA methylation, histone …

Epigenetics in cancer: fundamentals and beyond

S Biswas, CM Rao - Pharmacology & Therapeutics, 2017 - Elsevier
Activation of oncogenes or the deactivation of tumor suppressor genes has long been
established as the fundamental mechanism leading towards carcinogenesis. Although this …

Circular RNA ciRS-7—a promising prognostic biomarker and a potential therapeutic target in colorectal cancer

W Weng, Q Wei, S Toden, K Yoshida, T Nagasaka… - Clinical Cancer …, 2017 - AACR
Purpose: Colorectal cancer is one of the most common malignancies worldwide. Recently, a
novel circular RNA, ciRS-7, was proposed to be a potential miR-7 sponge. As miR-7, a …

Intranasal delivery of targeted polyfunctional gold–iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and …

UK Sukumar, RJC Bose, M Malhotra, HA Babikir… - Biomaterials, 2019 - Elsevier
The prognosis for glioblastoma (GBM) remains depressingly low. The biological barriers of
the brain present a major challenge to achieving adequate drug concentrations for GBM …

microRNAs (miRNAs) in glioblastoma multiforme (GBM)—recent literature review

M Makowska, B Smolarz, H Romanowicz - International Journal of …, 2023 - mdpi.com
Glioblastoma multiforme (GBM) is the most common, malignant, poorly promising primary
brain tumor. GBM is characterized by an infiltrating growth nature, abundant vascularization …

RNA modifications and cancer

P Haruehanroengra, YY Zheng, Y Zhou, Y Huang… - RNA biology, 2020 - Taylor & Francis
ABSTRACT RNA plays essential roles in not only translating nucleic acids into proteins, but
also in gene regulation, environmental interactions and many human diseases. Nature uses …

Targeting the oncogenic p53 mutants in colorectal cancer and other solid tumors

H Li, J Zhang, JHM Tong, AWH Chan, J Yu… - International journal of …, 2019 - mdpi.com
Colorectal cancer (CRC) is a kind of solid tumor and the third most common cancer type in
the world. It is a heterogeneous disease characterized by genetic and epigenetic …

Modulation of microRNA editing, expression and processing by ADAR2 deaminase in glioblastoma

S Tomaselli, F Galeano, S Alon, S Raho, S Galardi… - Genome biology, 2015 - Springer
Background ADAR enzymes convert adenosines to inosines within double-stranded RNAs,
including microRNA (miRNA) precursors, with important consequences on miRNA …

Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme

B England, T Huang, M Karsy - Tumor Biology, 2013 - Springer
Glioblastoma multiforme (GBM) is the most common primary malignancy in the brain and
confers a uniformly poor prognosis. Despite decades of research on the topic, limited …

[HTML][HTML] Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment

JB Kjersem, T Ikdahl, OC Lingjaerde, T Guren… - Molecular …, 2014 - Elsevier
The conventional first-line chemotherapy for metastatic colorectal cancer (mCRC) consists of
fluorouracil (5-FU) in combination with either oxaliplatin or irinotecan. We have explored …